CRC tissue; adjacent tissue / para-carcinoma tissues
LoVo; HCT116; HT29; SW480; RKO; FHC
-
proliferation (promotes); apoptosis (inhibits); cell cycle (promotes); migration (promotes); invasion (promotes); EMT (promotes); metastasis (promotes)
RT-qPCR; FISH / smFISH; Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; Transfection; CCK8; EdU Staining; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Western Blot; Clinical Sample Validation
suggests circLMNB1 as a novel biomarker for CRC
circLMNB1 (hsa_circ_0127801, from LMNB1) is up-regulated in colorectal cancer tissues and CRC cell lines. Functional assays show that circLMNB1 promotes malignant phenotypes (proliferation, migration/invasion, EMT) and suppresses apoptosis, partly accompanied by changes in EMT/apoptosis-related proteins (E-cadherin, N-cadherin, MMP2/9, Bax, caspase-3). It is proposed as a potential diagnostic biomarker for CRC.
0.7099
CircLMNB1 promotes colorectal cancer by regulating cell proliferation, apoptosis and epithelial-mesenchymal transition.
combined biological and clinical study